Laboratories Co., Ltd. is a listed company established in the year 1971. The manufacture and distribution of conventional medicine. Office and Factory are located at No.47 Soi Boonchana, Sukhumvit 59, Klong Ton
ยิ่งผู้ประกอบธุรกิจที่ได้มีการระดมทุนผ่านตราสารหนี้ที่มีความเสี่ยงสูง (“high yield bond”) อาจทำให้ผู้ประกอบธุรกิจขาดสภาพคล่อง และมีความเสี่ยงที่จะไม่สามารถชำระหนี้หรือไม่สามารถดำเนินกิจการต่อ
and Q2-2016 increased in similar rate. This is because the gross margin of the projects submitted was not very different. However, the projects delivered in the Q1-2017 are projects with relatively high
declined because of high employee benefit expenses and utility costs last year. In 2019, the high employee benefit expenses were due to an amendment of a labour protection law that employees were entitled to
representative in Thailand Information as of XX XX XXXX Name of the ARFP Fund Unit Class SRI Fund Class code Type of mutual fund Risk Level Low 1 2 3 4 5 6 7 8 High Risk Profile Explanation Investment policy and
Fund Unit Class SRI Fund Class code Type of mutual fund Risk Level Low 1 2 3 4 5 6 7 8 High Risk Profile Explanation Investment policy and strategy Calendar year performance and benchmarks over the past
Baht 222.92M in Q2’2016 to Baht 153.39M in Q2’2017 at 31.19% due to factory headcount was decreasing from last year and high competitive so there is a price cut from customers. - In Q2’17, the Company
Baht 222.92M in Q2’2016 to Baht 153.39M in Q2’2017 at 31.19% due to factory headcount was decreasing from last year and high competitive so there is a price cut from customers. - In Q2’17, the Company
wait for clarity from the election. Resulting in investment from the private sector Government slowdown high competition Customers postpone the plan and delay investment. Resulting in the results of
-high Net Worth Investor and High Net Worth Investor 08/02/2017 16/02/2017 3. Notification of the Securities and Exchange Commission  KorThor. 18/2554 Principles for Undertaking Securities and